All news

INOVIO Pharmaceuticals, Inc. (INO) Plans Public Stock Offering

Alpha Vantage · TradingView · · AI-summarised by FinFlash

INOVIO Pharmaceuticals, Inc. (INO) announced its intention to conduct an underwritten public offering of common stock, with underwriters potentially having a 30-day option for up to 15% of the shares. The size and specific terms of the offering are not yet determined and its completion is contingent on market conditions.

Read original source

INO company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.